He Jing, Wang Xi-E, Yuan Guo-Hong, Zhang Lian-Hai
Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University Surgical Department, Jinan Infectious Diseases Hospital, Jinan Department of Anesthesiology, Shouguang City People's Hospital, Shouguang City, Shandong Emergency Department, Zaozhuang Municipal Hospital, Zaozhuang, China.
Medicine (Baltimore). 2017 Sep;96(37):e7880. doi: 10.1097/MD.0000000000007880.
The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA).
In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis.
Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P < .00001), blood loss in drainage (P = .000), hemoglobin drop (P = .001), and total blood loss (P = .000).
TXA can decrease the need for transfusion as well as total blood loss in TSA patients. There was a negative correlation between the TXA dose and the need for transfusion and blood loss in drainage. Because the administration route and the dose of TXA were different, more studies are needed in order to identify the optimal dose and route.
本荟萃分析的目的是比较全肩关节置换术(TSA)后氨甲环酸(TXA)与安慰剂的疗效。
2017年4月,在PubMed、Embase、Web of Science、Cochrane图书馆和谷歌数据库中进行了基于计算机的系统检索。纳入比较TXA与安慰剂在TSA后减少失血方面的研究。终点指标为输血需求、引流管失血量、血红蛋白下降和总失血量。使用Stata 12.0软件进行荟萃分析。
六项研究共纳入637例患者,符合纳入标准。荟萃分析显示,与对照组相比,TXA治疗可减少输血需求(P<0.00001)、引流管失血量(P = 0.000)、血红蛋白下降(P = 0.001)和总失血量(P = 0.000)。
TXA可减少TSA患者的输血需求和总失血量。TXA剂量与输血需求和引流管失血量之间存在负相关。由于TXA的给药途径和剂量不同,需要更多研究以确定最佳剂量和途径。